Literature DB >> 28152401

123I-metaiodobenzylguanidine myocardial scintigraphy with early images alone is useful for the differential diagnosis of dementia with Lewy bodies.

Yuta Manabe1, Yoshitaka Inui2, Hiroshi Toyama2, Kenji Kosaka3.   

Abstract

123I-metaiodobenzylguanidine cardiac scintigraphy (MIBG) is a useful imaging technique for the diagnosis of dementia with Lewy bodies (DLB). However, MIBG has a serious disadvantage in that it demands a long examination time. The objective of this study was to evaluate statistically the usefulness of the heart/mediastinum ratio (H/M) from the early phase of MIBG for the differential diagnosis of DLB. In total, 113 patients were examined, including 32 non-DLB (19 with Alzheimer's dementia) and 79 DLB patients. The mean early-H/M ratio was 2.83 in the non-DLB group and 1.95 in the DLB group. The mean delayed-H/M ratio was 3.0 in the non-DLB group and 1.76 in the DLB group. With a cutoff point of 2.27 on early images, the sensitivity, specificity, and diagnostic accuracy were 65%, 94%, and 73%, respectively, and the area under the curve was 0.82, indicating moderate accuracy. This analysis indicates that images from the early phase of MIBG alone are sufficient for the differential diagnosis of Alzheimer's disease and DLB.
Copyright © 2017 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer-type dementia; Dementia with Lewy bodies; Heart/mediastinum ratio; Lewy body disease; Parkinson's disease; Parkinson's disease with dementia

Mesh:

Substances:

Year:  2017        PMID: 28152401     DOI: 10.1016/j.pscychresns.2016.12.011

Source DB:  PubMed          Journal:  Psychiatry Res Neuroimaging        ISSN: 0925-4927            Impact factor:   2.376


  7 in total

1.  Can early phase cardiac [123I]mIBG images be used to diagnose Lewy body disease?

Authors:  Gemma Roberts; Joseph P M Kane; Jim Lloyd; Michael Firbank; Paul Christopher Donaghy; George S Petrides; John-Paul Taylor; John O'Brien; Alan J Thomas
Journal:  Nucl Med Commun       Date:  2022-05-20       Impact factor: 1.698

Review 2.  Diagnosis and Management of Cognitive and Behavioral Changes in Dementia With Lewy Bodies.

Authors:  Babak Tousi
Journal:  Curr Treat Options Neurol       Date:  2017-10-09       Impact factor: 3.598

Review 3.  Roles of cardiac sympathetic neuroimaging in autonomic medicine.

Authors:  David S Goldstein; William P Cheshire
Journal:  Clin Auton Res       Date:  2018-07-30       Impact factor: 4.435

4.  Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies.

Authors:  Giovanni Palermo; Eleonora Del Prete; Ubaldo Bonuccelli; Roberto Ceravolo
Journal:  J Neurol       Date:  2020-06-27       Impact factor: 4.849

5.  Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies.

Authors:  Yuta Manabe; Toshinari Odawara; Osamu Konishi
Journal:  Psychogeriatrics       Date:  2019-02-19       Impact factor: 2.440

6.  Dynamic planar scintigraphy for the rapid kinetic measurement of myocardial 123I-MIBG turnover can identify Lewy body disease.

Authors:  Yoshitaka Kumakura; Yuji Shimizu; Masatsugu Hariu; Ken-Ichi Ichikawa; Norihito Yoshida; Masato Suzuki; Satoru Oji; Shinya Narukawa; Haruo Yoshimasu; Kyoichi Nomura
Journal:  EJNMMI Res       Date:  2021-12-14       Impact factor: 3.138

7.  Cardiac sympathetic denervation and synucleinopathy in Alzheimer's disease with brain Lewy body disease.

Authors:  Geidy E Serrano; David Shprecher; Michael Callan; Brett Cutler; Michael Glass; Nan Zhang; Jessica Walker; Anthony Intorcia; Charles H Adler; Holly A Shill; Erika Driver-Dunckley; Shyamal H Mehta; Christine M Belden; Edward Zamrini; Lucia I Sue; Daisy Vargas; Thomas G Beach
Journal:  Brain Commun       Date:  2020-01-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.